Why is Nectar Lifesci. falling/rising?
As of 06-Nov, Nectar Lifescience Ltd's stock price is Rs 13.91, down 1.77% and has fallen 13.12% over the last five days. The stock is underperforming significantly compared to the broader market, trading near its 52-week low and showing a year-to-date decline of 64.33%.
As of 06-Nov, Nectar Lifescience Ltd's stock price is currently at Rs 13.91, reflecting a decrease of Rs 0.25 or 1.77%. The stock has been underperforming significantly, having fallen consecutively for the last five days, resulting in a total decline of 13.12% during this period. It is also trading below all key moving averages, indicating a bearish trend. Additionally, the stock is close to its 52-week low, being only 4.74% away from Rs 13.25. The stock's performance over various periods shows a substantial year-to-date decline of 64.33%, while it has underperformed the sector by 1% today. Unfortunately, there is no information available regarding positive or negative factors that could influence the stock's movement.Broader market context indicates that the Sensex has experienced a decline of only 1.30% over the past week, contrasting sharply with Nectar Lifescience's 12.35% drop during the same timeframe. This suggests that the stock's poor performance is not aligned with broader market trends, where the benchmark has shown relative stability. The stark difference in returns, especially the year-to-date performance where the Sensex has gained 6.62%, highlights the significant challenges faced by Nectar Lifescience Ltd in attracting investor confidence and participation, as evidenced by the notable drop in delivery volume.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
